Lanean...
Medicare costs for neovascular age-related macular degeneration, 1994–2007
PURPOSE: To assess changes in Medicare payments for neovascular age-related macular degeneration (AMD) since introduction of anti-vascular endothelial growth factor (VEGF) therapies. DESIGN: Retrospective, longitudinal cohort study METHODS: Using the Medicare 5% sample, beneficiaries with new diagno...
Gorde:
| Egile Nagusiak: | , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2011
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3219793/ https://ncbi.nlm.nih.gov/pubmed/21843875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajo.2011.05.008 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|